< terug naar sprekers

Joop van Gerven


Joop van Gerven (1958) studied Medicine at Utrecht University. He obtained his MSc (cum laude) in 1982 and MD in 1984. He subsequently worked in the Department of Internal Medicine at Leiden University Medical Center (LUMC). In 1990 he completed a PhD-thesis on aldose reductase inhibitor treatment in diabetes mellitus. He was trained as a neurologist in Erasmus Medical Center Rotterdam (EMCR Dijkzigt Hospital) from 1988 to 1994. During that period, he consulted pharmaceutical industry on diabetic complications. He subsequently completed his training as a clinical pharmacologist. Since 1994 he is Director CNS Research at the Centre for Human Drug Research (CHDR) in Leiden, and is responsible for consultancy and research on central nervous system drugs and methods. He is Professor of Clinical Neuropsychopharmacology at Leiden University and Staff Neurologist at LUMC. His primary scientific interest is in demonstration of ‘proof of pharmacology’ for central nervous system-active agents during early phases of drug development. He has published almost 200 peer reviewed scientific articles and book chapters, and is a regular invited speaker on various aspects of this subject. Since 2011, Joop van Gerven has been the clinical pharmacologist, vice-chairman and acting chairman of the Central Committee on Research Involving Human Subjects (CCMO), the Dutch Clinical Trail Authority. In 2017 he was appointed chairman of the Committee.


Sessies

Versnelde beschikbaarheid van geneesmiddelen door ketensamenwerking

Versnelde beschikbaarheid van geneesmiddelen door ketensamenwerking